College aantekeningen
Pharm Exam 3
- Vak
- Pharmacology
- Instelling
- Rockhurst University
Class notes for Exam 3
[Meer zien]Voorbeeld 3 van de 20 pagina's
Voorbeeld 3 van de 20 pagina's
In winkelwagenVerkoper
Volgen
Voorbeeld van de inhoud
Pharmacology Exam 3HMG-CoA Reductase Inhibitors Prototype: Atorvastatin (Lipitor)
MOA: Blocks HMG-CoA reductase from completing synthesis of cholesterol in the liver (lowers cholesterol)
Admin: At HS (highest rates cholesterol synthesis)
Caution: Renal impairment, liver disease, heavy alcohol use, pregnancy category X
AE: GI effects (cramping, diarrhea, constipation), liver damage, myalgias; toxic: rhabdomyolysis with AKI
Nursing: Monitor liver and kidney function (toxicity); teach to report myalgias, no grapefruit juices (increases
levels-toxicity), lifestyle modification
Antiplatelet Agent/Salicylate Prototype: Aspirin (ASA)
MOA: Inhibit platelet aggregation (COX inhibitor)
Indication: Prevention of MI, TIA, ischemic CVA in high-risk populations (primary or secondary prevention)
Dose: 81-325mg PO daily (81mg is a “baby aspirin”)
AE: GI irritation (N/V, epigastric pain); bleeding – GI bleeding, hematuria, easy bruising; tinnitus (with toxicity)
Nursing: Take as directed, take with food, hold 1 week prior to procedure, monitor for s/s GI bleed (dark/bloody
stools)
Antiplatelet Agent Prototype: Clopidogrel (Plavix)
MOA: Inhibit platelet aggregation (alters signaling)
Indications: Prevent blood clot with hx of MI, ischemic stroke, or PAD; prevent clot with cardiac stent or graft
AE: Bleeding, flulike syndrome, dizziness, bruising, rash, pruritus
Nursing: Hold 5 days prior to procedure, bleeding precautions
Nursing Considerations/Antiplatelet Agents
Assessment
- Indication for medication (prevention blood clots)
- Clinical manifestations of bleeding
Interventions
- Bleeding precautions
- Avoid injury and falls
- Hold prior to procedure/surgery
- Educate patient on medication
Anticoagulants
Disrupt clotting cascade making it difficult for blood to clot
(They do not break up blood clot – they prevent them from growing)
Clotting Disorders/Complications/Treatment Goals
Clotting Disorder Chronic atrial Ischemic stroke Deep vein thrombosis Pulmonary embolism
fibrillation (embolus) (DVT) (PE)
Complication Ischemic stroke Tissue hypoxia/death Pulmonary embolism Tissue hypoxia/death
(embolus) (PE)
Treatment goals Prevent blood clot in Clot lysis: restore Slow clot growth: Slow clot growth:
atria perfusion inhibit propagation; inhibit new clots; clot
inhibits new clots lysis – surgical
,Diagnostic Lab: Clotting Time
Test Ref. Range Significance for Pharmacology
Prothrombin time (PT): Measures 11-12.5 seconds Prolonged: Warfarin therapy
clotting time of extrinsic pathway;
clotting factors II, V, VII, X
International Normalized Ratio (INR) 0.7-1.8 Measurement for adjusting warfarin
therapy
Therapeutic goal: 2.0-3.0
Activated Partial Thromboplastin 21-35 seconds Prolonged: Heparin therapy
Time (aPTT): Assess intrinsic clotting Measurement for adjusting heparin
cascade; clotting factors II, V, VIII, therapy
IX, XI, XII Therapeutic goal: 45-70 seconds
Anticoagulants/Thrombolytics: General Nursing Considerations
All anticoagulants have adverse effect of bleeding (non-fatal and fatal)
- Non-fatal: hematuria, epistaxis, bruising
- Fatal: hemorrhagic stroke, internal bleeding, GI bleeding (older adult high risk)
Reduce risk for injury and falls
Implement bleeding precautions
Contraindications:
- Pregnancy (except heparin/enoxaparin), bleeding disorders, hx of bleed, thrombocytopenia
Drug-drug:
- Antiplatelet agents, NSAIDS, herbals (all increase bleeding)
Indirect Thrombin Inhibitor (Anticoagulant) Prototype: Heparin
MOA: Disrupts clotting cascade; prolongs bleeding time
Route/Dose: 5000 units SQ 8 hours (prevention) or IV drip (protocol)
Indications: Prevent or treat DVT (SQ); treat PE (IV)
Contraindication: Pork allergy; pork abstention religion (Judaism, Muslim)
AE: Bleeding, heparin-induce thrombocytopenia (HIT), bruising at injection site
& usually long term symptom
Nursing: Rotate/monitor injection sites for SQ (do not admin IM), monitor platelet count; monitor aPTT (45-70 sec)
Reversal agent: Protamine sulfate (heparin short half-life, stop infusion)
Low Molecular Weight Heparin (Anticoagulant) Prototype: Enoxaparin (Lovenox)
MOA: Disrupts clotting cascade; prolongs bleeding time
Indications: Prevention or treatment of DVT
Route: 1mg/kg every 12 hours SQ longer given
half life so doesn't have to be
as
,
often as heparin
Contraindication: Pork allergy, pork abstention religion (Judaism, Muslim)
AE: Bleeding; bruising as injection site
Nursing: Admin deep SQ; do not aspirate or massage site; do not remove air bubble from prefilled syringe;
rotate/monitor injection site; monitoring of clotting time not necessary
Reversal agent: Protamine sulfate
Vitamin K Antagonist (Anticoagulant) Prototype: Warfarin (Coumadin)
MOA: Interfere with hepatic synthesis of vitamin K – dependent clotting factors; prolongs bleeding time
Route/Dose: 2-10 mg/day PO based on INR level
Indications: Chronic a-fib; artificial heart valves; prevent/treat DVT/PE
AE: GI effects (n/v), bleeding
Drug-drug: Antibiotics (monitor INR during therapy), amiodarone, herbals
Nursing: Monitor PT/INR (therapeutic INR 2.0-3.0); first oral anticoagulant drug on market
Reversal Agent: Vitamin K
, Warfarin Special Consideration
Dosing
- Daily (usually in the evening)
- If INR is greater than 3.0; HOLD and call prescribing provider
- Expect an order for vitamin K if INR is greater than 4.0 (PO or SQ)
Lab draws
- Dose change = next lab in 3 days
- Long term monitoring = weekly or monthly
Diet
- Teach patient to maintain consistent intake (avoid) vitamin K containing foods (high intake may decrease
warfarin effect)
Herbals to Avoid with Warfarin
St. Johns Wart
Garlic
Gingko
Ginger root
Chamomile
Factor Xa Inhibitor (Anticoagulant) Prototype: Rivaroxaban (Xarelto)
MOA: Disrupt clotting cascade; prolongs bleeding time
Route/Dose: 10mg PO daily (prevention); 15mg PO BID (treatment)
Indications: Chronic a-fib; prevent DVT and PE
AE: Bleeding
Nursing: No blood monitoring required
Reversal agent: Andexxa
Initial Management Anticoagulant Overdose
Assessment
-
Clinical manifestations of bleeding and vital signs (HR/BP/O2 sat)
Interventions
- Notify provider
- Draw labs as ordered: Hemoglobin/hematocrit (bleeding); platelets (bleeding, HIT); clotting times (PT/INR,
aPTT)
- Administer fluids (normal saline) and/or packed red blood cells as ordered
- Administer reversal agent as ordered
Thrombolytic Agent Prototype: Alteplase (Activase; tPA)
MOA: Local fibrinolysis (acute clot lysis)
Indications: Systemic; ischemic (embolic) stroke, PE, coronary thrombosis (MI); local: central venous catheter
occlusion
AE: Bleeding, hypotension, bradycardia, tachycardia
Contraindications: Many
Drugs Affecting Blood Coagulation: Nursing Assessment/Diagnosis/Outcomes
Assessment:
- Physical assessment with focus on cardiovascular and s/s bleeding
Dit zijn jouw voordelen als je samenvattingen koopt bij Stuvia:
Bewezen kwaliteit door reviews
Studenten hebben al meer dan 850.000 samenvattingen beoordeeld. Zo weet jij zeker dat je de beste keuze maakt!
In een paar klikken geregeld
Geen gedoe — betaal gewoon eenmalig met iDeal, creditcard of je Stuvia-tegoed en je bent klaar. Geen abonnement nodig.
Direct to-the-point
Studenten maken samenvattingen voor studenten. Dat betekent: actuele inhoud waar jij écht wat aan hebt. Geen overbodige details!
Veelgestelde vragen
Wat krijg ik als ik dit document koop?
Je krijgt een PDF, die direct beschikbaar is na je aankoop. Het gekochte document is altijd, overal en oneindig toegankelijk via je profiel.
Tevredenheidsgarantie: hoe werkt dat?
Onze tevredenheidsgarantie zorgt ervoor dat je altijd een studiedocument vindt dat goed bij je past. Je vult een formulier in en onze klantenservice regelt de rest.
Van wie koop ik deze samenvatting?
Stuvia is een marktplaats, je koop dit document dus niet van ons, maar van verkoper madisonbarton00. Stuvia faciliteert de betaling aan de verkoper.
Zit ik meteen vast aan een abonnement?
Nee, je koopt alleen deze samenvatting voor $8.49. Je zit daarna nergens aan vast.
Is Stuvia te vertrouwen?
4,6 sterren op Google & Trustpilot (+1000 reviews)
Afgelopen 30 dagen zijn er 64670 samenvattingen verkocht
Opgericht in 2010, al 15 jaar dé plek om samenvattingen te kopen
